Search company, investor...

Cothera Bioscience

Founded Year

2012

Stage

Series B | Alive

Total Raised

$30M

Last Raised

$30M | 2 yrs ago

About Cothera Bioscience

Cothera Bioscience focuses on the research and development of innovative tumor-targeted drugs.

Headquarters Location

Hangzhou, Zhejiang ,

China

Missing: Cothera Bioscience's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Cothera Bioscience's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Cothera Bioscience

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Cothera Bioscience is included in 1 Expert Collection, including Cancer.

C

Cancer

3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

Cothera Bioscience Patents

Cothera Bioscience has filed 1 patent.

The 3 most popular patent topics include:

  • Fluoroarenes
  • Indoles
  • Cannabinoids
patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/13/2012

8/25/2015

Vascular diseases, Coagulopathies, Hematology, Elementary geometry, Syndromes

Grant

Application Date

3/13/2012

Grant Date

8/25/2015

Title

Related Topics

Vascular diseases, Coagulopathies, Hematology, Elementary geometry, Syndromes

Status

Grant

Latest Cothera Bioscience News

Cothera Bioscience Acquires Zotiraciclib from Adastra Pharmaceuticals

Oct 6, 2021

Cothera to Advance Clinical Development of Oral Kinase Inhibitor with Unique Myc Depletion I want to thank all the physicians and dedicated healthcare providers who have put forward relentless effort on behalf of their patients as the Adastra team transitions zotiraciclib into Cothera.” — Scott Megaffin, Chief Executive Officer, Adastra PRINCETON, NEW JERSEY, USA, October … Continue reading "Cothera Bioscience Acquires Zotiraciclib from Adastra Pharmaceuticals"

Cothera Bioscience Frequently Asked Questions (FAQ)

  • When was Cothera Bioscience founded?

    Cothera Bioscience was founded in 2012.

  • Where is Cothera Bioscience's headquarters?

    Cothera Bioscience's headquarters is located at Hangzhou.

  • What is Cothera Bioscience's latest funding round?

    Cothera Bioscience's latest funding round is Series B.

  • How much did Cothera Bioscience raise?

    Cothera Bioscience raised a total of $30M.

  • Who are the investors of Cothera Bioscience?

    Investors of Cothera Bioscience include Sherpa Venture Capital, Legend Capital, CMB International Capital, Lang Sheng Investment, Kunlun Fund and 6 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.